Scarica l'app Stockscreener
164.56
1.45%
-2.38
Precedente Chiudi:
$166.94
Aprire:
$166.21
Volume 24 ore:
585.24K
Relative Volume:
0.35
Capitalizzazione di mercato:
$27.92B
Reddito:
$15.90B
Utile/perdita netta:
$1.28B
Rapporto P/E:
22.59
EPS:
7.2842
Flusso di cassa netto:
$2.21B
1 W Prestazione:
-9.83%
1M Prestazione:
-30.78%
6M Prestazione:
-13.90%
1 anno Prestazione:
-14.95%
Intervallo 1D:
$162.82
$167.55
Intervallo di 1 settimana:
$156.66
$185.00
Portata 52W:
$134.65
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
164.62 | 28.31B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
TMO
Thermo Fisher Scientific Inc
|
504.14 | 189.66B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
206.61 | 150.27B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
628.35 | 50.25B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
124.00 | 35.58B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
312.50 | 31.72B | 3.17B | 642.63M | 539.81M | 10.77 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-11-03 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
TD Cowen Adjusts Price Target on IQVIA to $174 From $245, Maintains Hold Rating - marketscreener.com
IQVIA HOLDINGS INC. SEC 10-K Report - TradingView
Crestwood Advisors Group LLC Acquires 19,022 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Momentum Shift: How volatile is IQVIA Holdings Inc stock2025 Market Sentiment & Weekly Return Optimization Plans - baoquankhu1.vn
Eagle Rock Investment Company LLC Increases Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Can IQVIA Holdings Inc. lead its sector in growthSwing Trade & Daily Technical Forecast Reports - mfd.ru
IQVIA Holdings Inc. $IQV Shares Acquired by Coronation Fund Managers Ltd. - MarketBeat
Cibc World Market Inc. Buys 10,658 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Is IQVIA Holdings Inc. (QTS) stock inflation resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Market Overview: What are Comerica Incorporateds growth levers2025 Major Catalysts & Real-Time Volume Triggers - baoquankhu1.vn
IQVIA Duke Alliance Highlights Obesity Trials And Potential Valuation Upside - Sahm
IQVIA Holdings Inc.: Inside the Data, AI, and Capital Strategy Shaping Its Next Chapter! - Smartkarma
Is the Options Market Predicting a Spike in IQVIA Stock? - Yahoo Finance
US prescriptions for Novo's Wegovy pill were 38,220 (not '38,909') for week ended Feb 6IQVIA data shared by analyst shows - marketscreener.com
Rhumbline Advisers Sells 25,227 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA (NYSE:IQV) Shares Gap DownTime to Sell? - MarketBeat
IQVIA Holdings Inc (IQV) Shares Gap Down to $166.13 on Feb 12 - GuruFocus
The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call - Finviz
Earnings growth of 3.6% over 3 years hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders - Yahoo Finance
75,170 Shares in IQVIA Holdings Inc. $IQV Purchased by Eubel Brady & Suttman Asset Management Inc. - MarketBeat
Cornerstone Investment Partners LLC Raises Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Will IQVIA Holdings Inc. benefit from sector rotationEarnings Growth Summary & Risk Adjusted Swing Trade Ideas - mfd.ru
IQVIA Holdings Inc (IQV) Shares Gap Down to $186.065 on Feb 10 - GuruFocus
Iqvia (IQV) Partners with Duke Institute to Innovate Obesity Res - GuruFocus
Global obesity trials get boost from new IQVIA–Duke research pact - Stock Titan
Compagnie Lombard Odier SCmA Cuts Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Aug EndMonth: Is IQVIA Holdings Inc stock influenced by commodity pricesTrade Performance Summary & Community Verified Swing Trade Signals - baoquankhu1.vn
IQVIA revenue for Q4 2025 up 10.3% to USD 4,364M - Medical Buyer
Candriam S.C.A. Grows Position in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Holdings, Inc. (IQV) Stock Analysis: A Promising 31.93% Upside Amid Robust Revenue Growth - DirectorsTalk Interviews
IQVIA Expands AI Data Partnerships As Investors Weigh Growth Prospects - Yahoo Finance
Rally Mode: Is Vipshop Holdings Limited Depositary Receipt subject to activist investor interestQuarterly Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), Haemonetics (HAE) and Denali Therapeutics (DNLI) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: IQVIA Holdings (IQV) and Molina Healthcare (MOH) - The Globe and Mail
Thrivent Financial for Lutherans Has $5.76 Million Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
IQVIA Fell 19% This Week. Could Shares Push Toward $260 in 2026? - TIKR.com
Jefferies lowers IQVIA stock price target to $255 on margin pressures By Investing.com - Investing.com South Africa
IQVIA Leans On AI And Boehringer Deal As Shares Struggle - Sahm
IQVIA Q4 Earnings Call Highlights - Yahoo Finance
Jefferies lowers IQVIA stock price target to $255 on margin pressures - Investing.com UK
IQV: JP Morgan Lowers Price Target While Maintaining Overweight Rating | IQV Stock News - GuruFocus
IQVIA stock price target lowered to $225 by Evercore ISI amid AI concerns By Investing.com - Investing.com Australia
UBS Adjusts IQVIA Holdings (IQV) Price Target to $240 Amidst Ste - GuruFocus
Jefferies Lowers Price Target for IQVIA Holdings (IQV) to $255 | - GuruFocus
IQV Analyst Rating Update: Stifel Lowers Price Target to $220 | IQV Stock News - GuruFocus
Barclays Analyst Lowers Price Target for IQV to $210 | IQV Stock News - GuruFocus
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term - Yahoo Finance
Leerink Partners Adjusts Price Target on IQVIA Holdings to $228 From $256, Maintains Outperform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on IQVIA Holdings to $225 From $250, Maintains Outperform Rating - marketscreener.com
Barclays Adjusts IQVIA Price Target to $210 From $230, Maintains Equal Weight Rating - marketscreener.com
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):